Kirsty Jensen, Giles D Makins, Anna Kaliszewska, Martin J Hulme, Edith Paxton, Elizabeth J Glass
Index: Int. J. Parasitol. 39(10) , 1099-108, (2009)
Full Text: HTML
The tick-borne protozoan parasite Theileria annulata causes a debilitating disease of cattle called Tropical Theileriosis. The parasite predominantly invades bovine macrophages (m phi) and induces host cell transformation by a mechanism that has not been fully elucidated. Infection is associated with loss of characteristic m phi functions and phenotypic markers, indicative of host cell de-differentiation. We have investigated the effect of T. annulata infection on the expression of the m phi differentiation marker c-maf. The up-regulation of c-maf mRNA levels observed during bovine monocyte differentiation to m phi was suppressed by T. annulata infection. Furthermore, mRNA levels for c-maf and the closely related transcription factor mafB were significantly lower in established T. annulata-infected cell-lines than in bovine monocyte-derived m phi. Treatment of T. annulata-infected cells with the theileriacidal drug buparvaquone induced up-regulation of c-maf and mafB, which correlated with altered expression of down-stream target genes, e.g. up-regulation of integrin B7 and down-regulation of IL12A. Furthermore, T. annulata infection is associated with the suppression of the transcription factors, Pu.1 and RUNX1, and colony stimulating factor 1 receptor (CSF1R) which are also involved in the regulation of monocyte/m phi differentiation. We believe these results provide the first direct evidence that T. annulata modulates the host m phi differentiation state, which may diminish the defence capabilities of the infected cell and/or promote cell proliferation. Musculoaponeurotic fibrosarcoma oncogene (MAF) transcription factors play an important role in cell proliferation, differentiation and survival; therefore, regulation of these genes may be a major mechanism employed by T. annulata to survive within the infected m phi.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Buparvaquone
CAS:88426-33-9 |
C21H26O3 |
Drug delivery systems for the topical treatment of cutaneous...
2012-09-01 [Expert Opin. Drug Deliv. 9(9) , 1083-97, (2012)] |
In-vivo therapeutic efficacy trial with artemisinin derivati...
2003-11-01 [J. Vet. Med. Sci. 65(11) , 1171-7, (2003)] |
Design, synthesis and in vitro evaluation of novel water-sol...
2004-10-01 [Eur. J. Pharm. Sci. 23(2) , 151-8, (2004)] |
Clinical efficacy and plasma concentrations of two formulati...
2006-08-01 [Res. Vet. Sci. 81(1) , 119-26, (2006)] |
Apoptosis of Theileria-infected lymphocytes induced upon par...
2008-12-01 [Biochimie 85(8) , 771-6, (2003)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved